author-photo

Yongqiang Zhao

Peking Union Medical College Hospital

49

Papers

1913

Citations

Citation Trend

Filter By

Papers (37) Sort By

Journal Conference Others

Phase 4 Safety and Efficacy Study of Antihemophilic Factor (Recombinant) in Previously Treated Chinese Patients With Severe/Moderately Severe Hemophilia A

2021 Clinical and Applied Thrombosis-Hemostasis
Show All
- Source
- Cite
- Save
Citations (0)
[Clinical and coagulation characteristics of 7 patients with critical COVID-2019 pneumonia and acro-ischemia]

2020 Chinese Journal of Hematology
Show All
- Source
- Cite
- Save
Citations (188)
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19

2020 The New England Journal of Medicine
Show All
- Source
- Cite
- Save
Citations (1317)
Reversible splenial lesion syndrome (RESLES) due to acute intermittent porphyria with a novel mutation in the hydroxymethylbilane synthase gene.

2020 Orphanet Journal of Rare Diseases
Show All
- Source
- Cite
- Save
Citations (2)
Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients.

2020 Journal of Thrombosis and Thrombolysis
Show All
- Source
- Cite
- Save
Citations (72)
Safety and Efficacy of Moroctocog Alfa (AF-CC) in Chinese Patients with Hemophilia A: Results of Two Open-Label Studies

2020 Journal of Blood Medicine
Show All
- Source
- Cite
- Save
Citations (0)
Severe high-molecular-weight kininogen deficiency due to a homozygous c.1456C > T nonsense variant in a large Chinese family.

2020 Journal of Thrombosis and Thrombolysis
Show All
- Source
- Cite
- Save
Citations (1)
Outcome of CARE: a 6‐year national registry of acquired haemophilia A in China

2019 British Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (8)
Bleeding assessment in haemophilia carriers—High rates of bleeding after surgical abortion and intrauterine device placement: A multicentre study in China

2019 Haemophilia
Show All
- Source
- Cite
- Save
Citations (4)
Efficacy and safety of prophylaxis with BAY 81-8973 in Chinese patients with severe haemophilia A enrolled in the LEOPOLD II trial.

2019 Haemophilia
Show All
- Source
- Cite
- Save
Citations (3)